Reading, United Kingdom

Manisha Naik


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Manisha Naik: Innovator in Pharmaceutical Chemistry

Introduction

Manisha Naik is a prominent inventor based in Reading, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues. With a total of 2 patents, her work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Manisha Naik's latest patents include groundbreaking inventions such as DGAT2 inhibitors. This invention provides compounds designed to treat patients suffering from hypertriglyceridemia and cardiovascular diseases, including dyslipidemia and atherosclerosis. Additionally, she has developed pyridine and pyrimidine derivatives, which are potent and selective inhibitors of p38 kinase. These compounds are useful in treating immune or inflammatory disorders, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Manisha has worked with notable companies such as Celltech R&D Limited and Eli Lilly and Company. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in pharmaceutical research and development.

Collaborations

Manisha has collaborated with esteemed colleagues, including Jeremy Martin Davis and Barry John Langham. These partnerships have further enriched her research and innovation efforts, leading to impactful discoveries in her field.

Conclusion

Manisha Naik stands out as a dedicated inventor whose work in pharmaceutical chemistry has the potential to improve patient outcomes significantly. Her innovative patents and collaborations reflect her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…